The Moran AMD Genetic Testing Assessment Study

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
Paul S. Bernstein
Study ID
NCT05265624
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 64 Years
Healthy Volunteers
Accepted

Interventions

  • Early disclosure of genetic testing results — BEHAVIORAL
    Early disclosure group receives results of genetic testing at Month 1
  • Late disclosure of genetic testing results — BEHAVIORAL
    Late disclosure group receives results of genetic testing at Month 12

Study Details

The goals of this study are: To assess the impact of genetic testing for Age-related Macular Degeneration (AMD) on lifestyle behaviors as measured by systemic and ocular carotenoid status.

Key Dates

Start date
Aug 3, 2022
Status verified
Sep 2025
Primary completion
Jul 12, 2024
Completion
Jul 12, 2024

Study Design

Enrollment
80 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Early Genetic Results Disclosure
    Early disclosure group receives results of genetic testing at Month 1
  • Active Comparator: Late Genetic Results Disclosure
    Late disclosure group receives results of genetic testing at Month 12

Primary Outcome Measure

Change in Skin Carotenoid Status in Response to Genetic Risk Disclosure as Measured by Reflectance Spectroscopy [ Time Frame: Baseline and Month 12 ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Utah John A. Moran Eye CenterSalt Lake CityUtah84132-

Find similar trials in Salt Lake City, UT

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
University of Utah John A. Moran Eye Center· Salt Lake City, UT

Related Studies